Replies to post #12 on Celgene CVR (CELGZ)

[diamondsaagbf24k]

CELGZ is a contingent value right developed when CELG acquired Abraxis science (I believe that the name). CELG paid a milestone payment in the form of a dividend for the FDA approval of Abraxane. I was told the stock therefore had to adjust. there is also a possibility to gain a percentage of the net sales of Abraxane for CELGZ holders. But if you find any further information please post

this is just information that I found. please do your own DD.